visualvisitorlogo
  • Our Platform downarrow
    Powerful Sales
    Intelligence     dashboard
    Platform Overview
    Buyer Intent Data
    B2B Prospect Data     Website Visitor ID Email Tracking
  • Why?downarrow
    Your Challenges Our Data See For Yourself
  • Pricing
  • Resourcesdownarrow
    Resellers
    Add Onsdrop
    Call Tracking     Keyword Level Tracking Reputation Management
    Integrations About Us
    Contactdrop
    Atlanta Jacksonville
    Blog Careers Support
    • Login Free Trial Schedule A Demo
    × Our Platform downarrow
    Why? downarrow
    Pricing Resources downarrow
    visualvisitorlogo ☰

    Veloxis Pharmaceuticals

    Get Full Access

    Description

    • Veloxis Pharmaceuticals is a specialty pharmaceutical company with offices in Hørsholm, Denmark and Edison, New Jersey. The companys lead product candidate is Envarsus® for immunosuppression, specifically organ transplantation. Veloxis unique, patented delivery technology, MeltDose®, can improve absorption and bioavailability at low scale up costs. Veloxis has a lipid lowering product, Fenoglide®, currently on the U.S. market that is commercialized through partner Santarus, Inc. Veloxis is listed on the NASDAQ OMX Copenhagen under the trading symbol OMX: VELO. For further information, please visit www.veloxis.com.
    • location

      Headquarters:1001 Winstead Drive Suite 310, Cary, North Carolina, United States

      More
    • Veloxis Pharmaceuticals phone

      Phone Number: +1 732-321-3200

    • Veloxis Pharmaceuticals website

      Website: https://www.veloxis.com

    • Veloxis Pharmaceuticals employees

      Employees:62

    • Veloxis Pharmaceuticals revenue

      Revenue:$50 - 100M

    • Veloxis Pharmaceuticals legal name

      Legal Name:Veloxis Pharmaceuticals

    • Veloxis Pharmaceuticals's Social Media

      Veloxis Pharmaceuticals linkedin
    • done Is this data correct?

    • |  NAICS Code: 541713  |

      Show More
    Person level website identification

    CEO for Veloxis Pharmaceuticals

    Mark Hensley

    Chief Executive Officer

    Person level website visitor identification

    Sell more in less time!

    Buyer intent data, anonymous visitor identification, first party data integration backed by a massive contact database that will supercharge your sales team. Schedule a demo to learn more!

    View Employees

    Ira Duarte

    Chief Financial Officer

    Ulf Meier-Kriesche

    Chief Scientific Officer

    Alastair Mcewan

    Chief Operations Officer

    Tunde Otulana

    Chief Medical Officer

    Steven Rizk

    Vice President, Scientific Affairs

    Frequently Asked Questions regarding Veloxis Pharmaceuticals

    • Where are Veloxis Pharmaceuticals's Headquarters?

      Veloxis Pharmaceuticals's Headquarters are in 1001 Winstead Drive Suite 310,Cary,North Carolina,United States

    • What is Veloxis Pharmaceuticals's phone number?

      Veloxis Pharmaceuticals's phone number is +1 732-321-3200

    • What is Veloxis Pharmaceuticals's official website?

      Veloxis Pharmaceuticals's official website is https://www.veloxis.com

    • What is Veloxis Pharmaceuticals's Revenue?

      Veloxis Pharmaceuticals's revenue is $50 - 100M

    • What is Veloxis Pharmaceuticals's NAICS code?

      Veloxis Pharmaceuticals's NAICS code is 541713

    • How many employees are working in Veloxis Pharmaceuticals

      Veloxis Pharmaceuticals has 62 employees

    • What is Veloxis Pharmaceuticals's Industry?

      Veloxis Pharmaceuticals is in the industry of Biotechnology

    • Who is Veloxis Pharmaceuticals's CEO?

      Veloxis Pharmaceuticals's CEO is Mark Hensley

    Company Directory